Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

BBHvsBMEDETF Comparison

ETF 1
BBH

VanEck Biotech ETF

This fund is part of
US Health Care
+0.53%
VS
ETF 2
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
+0.74%

VanEck Biotech ETF (BBH) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. BBH's top 1 sector exposures are Healthcare. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. BBH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.77% for BMED. BBH is up 9.98% year-to-date (YTD) with -$7M in YTD flows. BMED performs worse with 3.18% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of BBH and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BBH vs BMED performance and flow charts

Performance

-4.0-3.0-2.0-1.00.01.0%Jul 6Jul 13Jul 20Jul 27Aug 3

Cumulative Flows

Jul 6Jul 13Jul 20Jul 27Aug 3

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 08/04/2026
1M3MYTD1Y3Y5Y
Perf.
BBH
BMED
-1.02%-0.81%
+12.06%+12.05%
+9.98%+3.18%
+26.54%+24.95%
+32.94%+30.19%
-1.92%+2.75%
Flows
BBH
BMED
--
-$4M-
-$7M+$4M
-$28M+$6M
-$180M+$4M
-$139M+$5M
Volatility and drawdown
3M1Y3Y5Y
Volatility
BBH
BMED
+21.02%+17.42%
+19.52%+16.01%
+19.25%+16.08%
+21.50%+17.71%
Max drawdown
BBH
BMED
-5.29%-4.62%
-10.54%-14.71%
-22.78%-19.76%
-39.88%-33.96%
Max drawdown duration
BBH
BMED
28d30d
150d194d
440d237d
1821d1586d
Trading data

Create an account to view trading data

Join for free
BBH
BMED
Last sale
8/5/2026 at 4:56 PM
$210.50
$31.21
Previous close
08/04/2026
$208.03
$30.88
Consolidated volume
08/04/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
BBH
BMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 8/5/2026 at 4:56 PM
Live
Closed
BBH
BMED
Last price
$210.50
$31.21
1D performance
+1.19%
+1.08%
AuM$404.99 M$11.22 M
E/R0.35%0.77%
Characteristics
BBH
BMED
Management strategyPassiveActive
ProviderVanEckiShares
BenchmarkMVIS US Listed Biotech 25 Index-
N° of holdings2452
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011September 29, 2020
ESGNoNo
Advertisement
Exposure

Countries

BBH
USA
87.33%
Other
12.67%
BMED
USA
88.93%
Other
11.07%

Sectors

BBH
Healthcare
100%
BMED
Healthcare
97.21%
Other
2.79%
Advertisement

Diversification

BBH

Total weight of top 15 holdings out of 15

85.08%
BMED

Total weight of top 15 holdings out of 15

59.83%

Top 15 holdings

Data as of June 30, 2026
BBH
Amgen, Inc.
15.15%
Gilead Sciences, Inc.
12.75%
Vertex Pharmaceuticals, Inc.
9.15%
Regeneron Pharmaceuticals, Inc.
6.26%
Revolution Medicines, Inc.
5.41%
Natera, Inc.
4.92%
argenx SE
4.88%
IQVIA Holdings, Inc.
4.30%
Alnylam Pharmaceuticals, Inc.
3.73%
Biogen, Inc.
3.63%
Moderna, Inc.
3.34%
Illumina, Inc.
3.26%
BeOne Medicines Ltd.
2.85%
United Therapeutics Corp.
2.84%
Insmed, Inc.
2.62%
BMED
Merck & Co., Inc.
5.90%
Johnson & Johnson
5.13%
Gilead Sciences, Inc.
4.77%
Edwards Lifesciences Corp.
4.70%
BlackRock Cash Funds - Treasury
4.08%
Biogen, Inc.
3.79%
Moderna, Inc.
3.78%
Thermo Fisher Scientific, Inc.
3.69%
Charles River Laboratories International, Inc.
3.67%
Danaher Corp.
3.59%
Waters Corp.
3.52%
AbbVie, Inc.
3.49%
Amgen, Inc.
3.44%
Mettler-Toledo International, Inc.
3.17%
Vertex Pharmaceuticals, Inc.
3.11%
Frequently asked questions about BBH and BMED

How have the BBH and BMED ETFs performed in 2026?

As of August 4, 2026, BBH is up 9.98% year-to-date (YTD), while BMED has returned 3.18%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: BBH or BMED?

Year-to-date, the BBH ETF saw -$7M in flows, compared to +$4M for BMED.

Which ETF is more volatile: BBH or BMED?

Over the past year, BBH had a volatility of 19.52%, while BMED experienced 16.01%.

Which ETF is bigger: BBH or BMED?

As of August 4, 2026, BBH holds $404.99 M in assets under management (AUM), while BMED manages $11.22 M.

What sectors do the BBH and BMED ETFs invest in?

BBH leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the BBH ETF and BMED ETF?

BBH top holdings include Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. BMED holds in its top three: Merck & Co., Inc., Johnson & Johnson and Gilead Sciences, Inc..

Which ETF is more diversified: BBH or BMED?

BBH holds 24 securities with 85.08% of its assets in the top 15. BMED has 55 securities and a top 15 weight of 59.83%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder